LOMUSTINE CAS 13010-47-4
LOMUSTINE CAS 13010-47-4
Formula: The chemical formula for Lomustine is C9H16Cl2N2O2.
Description: Lomustine, also known as CCNU (1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea), is a chemotherapy medication. It is a yellow to orange crystalline powder, practically insoluble in water.
Category: Lomustine belongs to the class of alkylating agents, which work by damaging the DNA of cancer cells, ultimately inhibiting their growth and replication.
Use: Lomustine is primarily used in the treatment of various types of cancer, including brain tumors (such as gliomas and glioblastomas), Hodgkin’s lymphoma, and certain types of lung cancer. It is often used when other treatments have failed or as part of combination chemotherapy regimens.
Dosage & Administration: The dosage of Lomustine depends on factors such as the type and stage of cancer being treated, the patient’s overall health, and other medications they may be taking. It is typically administered orally in the form of capsules. Dosages are usually calculated based on body surface area or body weight and are administered every 6 to 8 weeks. The specific dosage regimen should be determined by a healthcare professional experienced in the use of chemotherapy drugs.
Appearance: Lomustine is commonly found as a yellow to orange crystalline powder.
Package Size: Lomustine is available in various package sizes depending on the manufacturer and intended use. It is commonly supplied in bottles or blister packs containing capsules, with package sizes ranging from a few capsules to larger quantities for multiple treatment cycles.
LOMUSTINE CAS 13010-47-4
Formula: The chemical formula for Lomustine is C9H16Cl2N2O2.
Description: Lomustine, also known as CCNU (1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea), is a chemotherapy medication. It is a yellow to orange crystalline powder, practically insoluble in water.
Category: Lomustine belongs to the class of alkylating agents, which work by damaging the DNA of cancer cells, ultimately inhibiting their growth and replication.
Use: Lomustine is primarily used in the treatment of various types of cancer, including brain tumors (such as gliomas and glioblastomas), Hodgkin’s lymphoma, and certain types of lung cancer. It is often used when other treatments have failed or as part of combination chemotherapy regimens.
Dosage & Administration: The dosage of Lomustine depends on factors such as the type and stage of cancer being treated, the patient’s overall health, and other medications they may be taking. It is typically administered orally in the form of capsules. Dosages are usually calculated based on body surface area or body weight and are administered every 6 to 8 weeks. The specific dosage regimen should be determined by a healthcare professional experienced in the use of chemotherapy drugs.
Appearance: Lomustine is commonly found as a yellow to orange crystalline powder.
Package Size: Lomustine is available in various package sizes depending on the manufacturer and intended use. It is commonly supplied in bottles or blister packs containing capsules, with package sizes ranging from a few capsules to larger quantities for multiple treatment cycles.
